Christos V. Bourantas1,2*, MD, PhD; Erhan Tenekecioglu3, MD, PhD; Maria Radu4, MD, PhD; Lorenz Räber5, MD, PhD; Patrick W. Serruys6, MD, PhD
1. Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom; 2. Institute of Cardiovascular Sciences, University College London, London, United Kingdom; 3. Department of Interventional Cardiology, Erasmus University Med
It has been 40 years since percutaneous coronary intervention (PCI) was introduced into the clinical setting. Over these years significant advances in device technology and the invention of new therapeutic strategies have bro